Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MSCI vs GSK✓SelectedUSD · GSKMSCI vs GSK performance historyLatest closeAs of+0.96%11/16
Stock and ETF performance explorer

MSCI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+833.2%
GSK return
+108.8%
Excess return
+724.4%
Maximum drawdown
-43.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%-0.1%+1.0%+1.0%
7D+3.1%-1.3%+4.4%+3.6%
30D+17.1%+2.7%+14.4%+16.0%
3M+17.1%+2.7%+14.4%+15.8%
6M+19.1%+3.3%+15.8%+17.0%
YTD+17.5%+6.5%+11.0%+12.7%
1Y+19.3%+10.7%+8.6%+12.5%
3Y+31.7%+64.4%-32.6%+0.2%
5Y+4.4%+46.7%-42.3%-17.6%
All+833.2%+108.8%+724.4%+510.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling